What is the role of intensive cholesterol lowering in the treatment of acute coronary syndromes?

Waters, D D; Hsue, P Y

Waters, D D; Hsue, P Y.

Affiliation

Waters DD; Division of Cardiology, San Francisco General Hospital, San Francisco, California 94110, USA. dwaters@medsfgh.ucsf.edu

Am J Cardiol ; 88(7B): 7J-16J, 2001 Oct 11.

Article in En | MEDLINE | ID: mdl-11595193

Subject(s)

Angina, Unstable/drug therapy; Anticholesteremic Agents/therapeutic use; Coronary Artery Disease/drug therapy; Heptanoic Acids/therapeutic use; Hypercholesterolemia/drug therapy; Myocardial Infarction/drug therapy; Pyrroles/therapeutic use; Angina, Unstable/blood; Anticholesteremic Agents/adverse effects; Atorvastatin; Cholesterol/blood; Clinical Trials as Topic; Coronary Artery Disease/blood; Follow-Up Studies; Heptanoic Acids/adverse effects; Humans; Hypercholesterolemia/blood; Myocardial Infarction/blood; Pyrroles/adverse effects; Treatment Outcome

Search on Google

XML

PubMed Links

Collection: 01-internacional Database: MEDLINE Main subject: Pyrroles / Coronary Artery Disease / Heptanoic Acids / Hypercholesterolemia / Angina, Unstable / Anticholesteremic Agents / Myocardial Infarction Type of study: Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Humans Language: En Journal: Am J Cardiol Year: 2001 Type: Article Affiliation country: United States

Search on Google

XML

PubMed Links